DK11996A - Ny forbindelse, fremgangsmåde til fremstilling deraf samt anvendelse deraf til fremstilling af et medikament - Google Patents

Ny forbindelse, fremgangsmåde til fremstilling deraf samt anvendelse deraf til fremstilling af et medikament Download PDF

Info

Publication number
DK11996A
DK11996A DK011996A DK11996A DK11996A DK 11996 A DK11996 A DK 11996A DK 011996 A DK011996 A DK 011996A DK 11996 A DK11996 A DK 11996A DK 11996 A DK11996 A DK 11996A
Authority
DK
Denmark
Prior art keywords
medicament
manufacture
preparation
new compound
compound
Prior art date
Application number
DK011996A
Other languages
Danish (da)
English (en)
Inventor
Victor Witold Jacewicz
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK11996(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9502297.6A external-priority patent/GB9502297D0/en
Priority claimed from GBGB9503112.6A external-priority patent/GB9503112D0/en
Priority claimed from GBGB9509807.5A external-priority patent/GB9509807D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of DK11996A publication Critical patent/DK11996A/da
Priority to DK200100774A priority Critical patent/DK200100774A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK011996A 1995-02-06 1996-02-05 Ny forbindelse, fremgangsmåde til fremstilling deraf samt anvendelse deraf til fremstilling af et medikament DK11996A (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK200100774A DK200100774A (da) 1995-02-06 2001-05-16 Ny forbindelse, fremgangsmåde til fremstilling deraf, samt anvendelse deraf til fremstilling af et medikament

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9502297.6A GB9502297D0 (en) 1995-02-06 1995-02-06 Novel compound
GBGB9503112.6A GB9503112D0 (en) 1995-02-17 1995-02-17 Novel compound
GBGB9509807.5A GB9509807D0 (en) 1995-05-15 1995-05-15 Novel compounds

Publications (1)

Publication Number Publication Date
DK11996A true DK11996A (da) 1996-08-07

Family

ID=27267578

Family Applications (2)

Application Number Title Priority Date Filing Date
DK011996A DK11996A (da) 1995-02-06 1996-02-05 Ny forbindelse, fremgangsmåde til fremstilling deraf samt anvendelse deraf til fremstilling af et medikament
DKPA200100223 DK200100223A (es) 1995-02-06 2001-02-12

Family Applications After (1)

Application Number Title Priority Date Filing Date
DKPA200100223 DK200100223A (es) 1995-02-06 2001-02-12

Country Status (47)

Country Link
EP (3) EP0808314B1 (es)
JP (2) JP2915338B2 (es)
KR (1) KR100289885B1 (es)
CN (3) CN1090187C (es)
AR (2) AR001982A1 (es)
AT (1) AT407528B (es)
AU (2) AU4786496A (es)
BE (1) BE1009112A3 (es)
BG (1) BG62967B1 (es)
BR (1) BR9600534A (es)
CA (4) CA2211522C (es)
CH (3) CH689804A5 (es)
CZ (1) CZ297171B6 (es)
DE (3) DE19603797C2 (es)
DK (2) DK11996A (es)
DZ (1) DZ1989A1 (es)
ES (1) ES2114471B1 (es)
FI (3) FI111544B (es)
FR (1) FR2730232B1 (es)
GR (1) GR1002466B (es)
HK (1) HK59397A (es)
HU (1) HUP9600255A1 (es)
IE (1) IE80500B1 (es)
IL (1) IL117035A (es)
IT (1) IT1289532B1 (es)
LU (1) LU88711A1 (es)
LV (1) LV11618B (es)
MA (1) MA23802A1 (es)
MC (1) MC2411A1 (es)
MX (1) MX9600484A (es)
MY (1) MY132529A (es)
NL (1) NL1002248C2 (es)
NO (3) NO301009B1 (es)
NZ (1) NZ280943A (es)
OA (1) OA10261A (es)
PL (1) PL189247B1 (es)
PT (1) PT101827B (es)
RO (1) RO112426B1 (es)
RU (1) RU2125052C1 (es)
SE (1) SE521084C2 (es)
SG (1) SG43787A1 (es)
SI (2) SI21923B (es)
SK (1) SK283608B6 (es)
TR (1) TR199600096A2 (es)
TW (1) TW503238B (es)
UA (1) UA49796C2 (es)
WO (1) WO1996024595A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3882224B2 (ja) 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
EP1384720A1 (en) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Process for drying paroxetine hydrochloride
EP0937152A2 (en) * 1996-07-15 1999-08-25 Smithkline Beecham Plc Screening for and use of an esterase for a stereospecific resolution
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
DK0994872T3 (da) 1997-06-10 2001-05-28 Synthon Bv 4-phenylpiperidin-forbindelser
EP0987256B1 (de) * 1997-08-08 2001-10-17 Aventis Pharma Deutschland GmbH Kristallform von N-(4-Trifluormethylphenyl)-5-methylisoxazol-4-carbonsäureamid
GB9726907D0 (en) * 1997-12-19 1998-02-18 Smithkline Beecham Plc Novel compounds
CN1300286A (zh) * 1998-03-16 2001-06-20 史密丝克莱恩比彻姆有限公司 帕罗西丁的晶形
AU2003200534B2 (en) * 1998-03-24 2004-12-02 Smithkline Beecham Plc Paroxetine compositions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9812941D0 (en) * 1998-06-16 1998-08-12 Smithkline Beecham Plc Method of treatment
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
CN1321155A (zh) * 1998-08-07 2001-11-07 史密丝克莱恩比彻姆有限公司 制备非晶性脱水型帕罗西汀盐酸盐的方法
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
GB9826175D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826176D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826178D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826171D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel compounds
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
JP2002531452A (ja) * 1998-11-30 2002-09-24 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 混合パロキセチンプロパン−２−オール溶媒和物
GB9826242D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9828767D0 (en) * 1998-12-29 1999-02-17 Smithkline Beecham Plc Novel process
AU3810100A (en) * 1999-03-12 2000-10-04 Basf Aktiengesellschaft Stable pharmaceutical application form for paroxetin anhydrate
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
GB9914585D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
GB9919001D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923445D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
WO2002022609A1 (fr) * 2000-09-14 2002-03-21 Asahi Glass Company, Limited Procede de production de sel de paroxetine sensiblement exempt de solvant organique
IL163593A0 (en) * 2002-02-22 2005-12-18 Teva Pharma Preparation of paroxetine involving novel intermediates
US7563930B2 (en) * 2005-11-22 2009-07-21 Teva Pharmaceutical Industries Ltd Crystal forms of Cinacalcet HCI and processes for their preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
DK716088D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
CA2096853A1 (en) * 1990-11-24 1992-05-25 Anthony Michael Johnson Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
CZ297171B6 (cs) 2006-09-13
DE19603797A1 (de) 1996-08-14
CH688353A5 (de) 1997-08-15
KR960031409A (ko) 1996-09-17
NL1002248C2 (nl) 1996-09-11
DK200100223A (es) 2001-02-12
NL1002248A1 (nl) 1996-08-06
DE69631298D1 (de) 2004-02-12
FI20030162A (fi) 2003-02-03
CA2210022A1 (en) 1996-08-07
CA2210023A1 (en) 1996-08-07
SI9600036A (en) 1996-10-31
FI111544B (fi) 2003-08-15
NO301009B3 (es) 2003-01-06
NZ280943A (en) 1997-01-29
PT101827A (pt) 1996-09-30
CA2211522A1 (en) 1996-08-07
HU9600255D0 (en) 1996-03-28
HUP9600255A1 (en) 1997-03-28
EP0808314B1 (en) 2002-06-12
ES2114471B1 (es) 1999-08-16
NO960472L (no) 1996-08-07
CH689229A5 (de) 1998-12-31
FI20030370A (fi) 2003-03-12
PT101827B (pt) 1997-08-29
NO20015070L (no) 1996-08-07
JP2915338B2 (ja) 1999-07-05
SK283608B6 (sk) 2003-10-07
EP1378508A1 (en) 2004-01-07
BR9600534A (pt) 1997-05-13
BG100333A (bg) 1996-08-30
SI9600036B (sl) 2006-12-31
KR100289885B1 (ko) 2001-05-15
PL189247B1 (pl) 2005-07-29
JPH11228571A (ja) 1999-08-24
FI960519A (fi) 1996-08-07
SE9600406L (sv) 1996-08-07
TR199600096A2 (tr) 1996-08-21
AR001982A1 (es) 1998-01-07
AR036856A2 (es) 2004-10-06
CN1143643A (zh) 1997-02-26
FI960519A0 (fi) 1996-02-05
SI21923B (sl) 2006-12-31
ITMI960203A1 (it) 1997-08-05
CN1636993A (zh) 2005-07-13
CA2168829A1 (en) 1996-08-07
NO20015070D0 (no) 2001-10-18
IL117035A0 (en) 1996-09-12
RU2125052C1 (ru) 1999-01-20
SE521084C2 (sv) 2003-09-30
UA49796C2 (uk) 2002-10-15
DE19603797C2 (de) 1998-11-12
FR2730232A1 (fr) 1996-08-09
MY132529A (en) 2007-10-31
MC2411A1 (fr) 1996-12-02
MX198371B (es) 2000-08-29
AU701518C (en) 2006-12-07
LV11618A (lv) 1996-12-20
AU4786496A (en) 1996-08-27
SK14396A3 (en) 1996-11-06
ATA21096A (de) 2000-08-15
CN1216055C (zh) 2005-08-24
SE9600406D0 (sv) 1996-02-05
MA23802A1 (fr) 1996-10-01
DZ1989A1 (fr) 2002-10-15
AU4332896A (en) 1996-08-15
EP1136490A1 (en) 2001-09-26
IE960104A1 (en) 1996-08-07
AU701518B2 (en) 1999-01-28
NO311519B1 (no) 2001-12-03
DE69621777T2 (de) 2003-01-02
RO112426B1 (ro) 1997-09-30
CA2210022C (en) 2005-09-13
DE69631298T2 (de) 2004-11-18
IT1289532B1 (it) 1998-10-15
CN1310180A (zh) 2001-08-29
LV11618B (en) 1997-04-20
PL312646A1 (en) 1996-08-19
LU88711A1 (fr) 1996-08-23
MX9600484A (es) 1997-01-31
EP0808314A1 (en) 1997-11-26
NO970939D0 (no) 1997-02-28
CZ32096A3 (en) 1996-08-14
HK59397A (en) 1997-05-16
IL117035A (en) 2000-02-29
CN1289496C (zh) 2006-12-13
GR1002466B (el) 1996-11-06
DE69621777D1 (de) 2002-07-18
BE1009112A3 (fr) 1996-11-05
AT407528B (de) 2001-04-25
OA10261A (en) 1997-09-19
IE80500B1 (en) 1998-08-12
NO301009B1 (no) 1997-09-01
NO970939L (no) 1996-08-07
FR2730232B1 (fr) 1997-08-01
SG43787A1 (en) 1997-11-14
CA2168829C (en) 1997-12-16
BG62967B1 (bg) 2000-12-29
SI21923A (sl) 2006-06-30
WO1996024595A1 (en) 1996-08-15
ES2114471A1 (es) 1998-05-16
CH689804A5 (de) 1999-11-30
JPH08245620A (ja) 1996-09-24
CN1090187C (zh) 2002-09-04
CA2211522C (en) 1999-12-07
EP1136490B1 (en) 2004-01-07
NO960472D0 (no) 1996-02-05
TW503238B (en) 2002-09-21
ITMI960203A0 (es) 1996-02-05
CA2210023C (en) 1999-02-09

Similar Documents

Publication Publication Date Title
DK11996A (da) Ny forbindelse, fremgangsmåde til fremstilling deraf samt anvendelse deraf til fremstilling af et medikament
NO976084L (no) Ny, stabil legemiddeltilberedning for dannelse av drivgassfrie aerosoler
NO973612D0 (no) Nytt farmasöytisk preparat
DE69510024T2 (de) Spritze
IS4662A (is) Innúðatæki
DK1005475T3 (da) Fremgangsmåde til fremstilling af Glufosinat samt mellemprodukter dertil
PT1002243E (pt) Metodo para a preparacao de materiais para dispositivos oftalmicos hidrofilicos dobraveis
IS4698A (is) Innúðatæki
DK0830166T3 (da) Inhalationsapparat
NO992401D0 (no) Ny fremgangsmÕte for fremstilling av metoprolol
NO964190A (no) Terapeutisk smertestillende middel inneholdende "Nimesulid", samt fremgangsmåte ved fremstilling derav
NO20003625L (no) Ny fremgangsmÕte for fremstilling av et ketimin
FI973229A (fi) Uusi farmaseuttinen koostumus
NO972239L (no) Ny replikasjonsprosess
NO993627D0 (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
NO903513L (no) Fremgangsmaate for fremstilling av cykliske neurokinin a-antagonister.
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
NO973611D0 (no) Nytt farmasöytisk preparat
NO890803D0 (no) Fremgangsmaate for fremstilling av trisubstituerte aminer.
NO307704B1 (no) 8-trifluormetylkinolinkarboksylsyre-derivat, medisinsk preparat inneholdende derivatet, samt anvendelse av et medisinsk preparat
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
EE9500004A (et) Meetod bensaldehüüdi valmistamiseks
DK0863874T3 (da) Fremgangsmåde til fremstilling af dioxoazabicyclohexaner
DK0802901T3 (da) Hidtil ukendte carbamatforbindelser indeholdende en thiocarbamoylgruppe samt fremgangsmåde til fremstilling af samme
NO972682D0 (no) Ny fremgangsmåte for fremstilling av sameridin

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment